Use of disease-modifying therapies in paediatric relapsing remitting multiple sclerosis in the UK: A multi-centre retrospective study

被引：0
|
作者：
Abdel-Mannan, O. [1 ]
Manchoon, C. [2 ]
Rossor, T. [3 ]
Benetou, C. [2 ]
Mahal, S. [1 ]
Crichton, S. [2 ]
Wright, S. [4 ]
Chitre, M. [3 ]
Wassmer, E. [4 ]
Lim, M. [2 ]
Ciccarelli, O. [5 ]
Hemingway, C. [1 ]
Hacohen, Y. [1 ,5 ]
机构：
[1] Great Ormond St Hosp Sick Children, Neurol, London, England
[2] Evelina Childrens Hosp, Clin Neurosci, London, England
[3] Addenbrookes Hosp, Paediat Neurol, Cambridge, England
[4] Birmingham Childrens Hosp, Neurol, Birmingham, W Midlands, England
[5] UCL Queens Sq Inst Neurol, Neuroinflammat, London, England
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P377
引用
收藏
页码：148 / 149
页数：2
相关论文
共 50 条
  • [1] Use of disease-modifying therapies in paediatric relapsing remitting multiple sclerosis in the UK: A multi-centre retrospective study
    Abdel-Mannan, O.
    Manchoon, C.
    Rossor, T.
    Mahal, S.
    Benetou, C.
    Chrichton, S.
    Wright, S.
    Chitre, M.
    Wassmer, E.
    Lim, M.
    Hemingway, C.
    Ciccarelli, O.
    Hacohen, Y.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 229 - 229
  • [2] Disease-modifying therapies in relapsing-remitting multiple sclerosis
    Gonzalez-Andrade, Fabricio
    Luis Alcaraz-Alvarez, Jose
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2010, 6 : 365 - 373
  • [3] Oral disease-modifying therapies for relapsing-remitting multiple sclerosis
    Thomas, Rachel Hutchins
    Wakefield, Richard A.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (01) : 25 - 38
  • [4] Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United Kingdom
    Abdel-mannan, Omar A.
    Manchoon, Celeste
    Rossor, Thomas
    Southin, Justine-Clair
    Tur, Carmen
    Brownlee, Wallace
    Byrne, Susan
    Chitre, Manali
    Coles, Alasdair
    Forsyth, Rob
    Kneen, Rachel
    Mankad, Kshitij
    Ram, Dipak
    West, Siobhan
    Wright, Sukhvir
    Wassmer, Evangeline
    Lim, Ming
    Ciccarelli, Olga
    Hemingway, Cheryl
    Hacohen, Yael
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2021, 8 (04):
  • [5] Pregnancy and disease-modifying therapies in patients with relapsing-remitting multiple sclerosis
    Oztekin, N. S.
    Oztekin, M. F.
    [J]. MULTIPLE SCLEROSIS, 2006, 12 : S95 - S96
  • [6] Efficacy of disease-modifying therapies in relapsing remitting multiple sclerosis: A systematic comparison
    Freedman, Mark S.
    Hughes, Bruce
    Mikol, Daniel D.
    Bennett, Randy
    Cuffel, Brian
    Divan, Vamil
    LaVallee, Nicole
    Al-Sabbagh, Ahmad
    [J]. EUROPEAN NEUROLOGY, 2008, 60 (01) : 1 - 11
  • [7] Disease-Modifying Therapies for Relapsing–Remitting Multiple Sclerosis: A Network Meta-Analysis
    Rosa C. Lucchetta
    Fernanda S. Tonin
    Helena H. L. Borba
    Letícia P. Leonart
    Vinicius L. Ferreira
    Aline F. Bonetti
    Bruno S. Riveros
    Jefferson Becker
    Roberto Pontarolo
    Fernando Fernandez-Llimós
    Astrid Wiens
    [J]. CNS Drugs, 2018, 32 : 813 - 826
  • [8] Discontinuation of disease-modifying therapies in relapsing remitting multiple sclerosis - outcome and prognostic factors
    Bsteh, G.
    Feige, J.
    Ehling, R.
    Hegen, H.
    Auer, M.
    Di Pauli, F.
    Deisenhammer, F.
    Berger, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 644 - 644
  • [9] Comorbidity and persistence of disease-modifying therapy use in relapsing remitting multiple sclerosis
    Parks, Natalie E.
    Andreou, Pantelis
    Marrie, Ruth Ann
    Fisk, John
    Bhan, Virender
    Kirkland, Susan A.
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 56
  • [10] The Effects of Disease-Modifying Therapies on Oxidative Stress in Patients With Relapsing-Remitting Multiple Sclerosis
    Topic, Aleksandra
    Vasic, Marija
    Markovic, Bojan
    Milinkovic, Neda
    Dincic, Evica
    [J]. CLINICAL NEUROPHARMACOLOGY, 2022, 45 (06) : 157 - 161
12345